Supplies of diagnostic tests for SARS-CoV-2, the virus that causes COVID-19 (coronavirus), are still limited in many countries, and there is uncertainty about how to allocate the scarce supply across alternative types of testing (use cases). This Research & Policy Brief quantifies the cost-effectiveness of five alternative diagnostic use cases in terms of tests required per death averted. Across use cases, a single death can be averted by administering...
Voir la suite
INFORMATION
-
2021/02/23
-
Fiche
-
156888
-
1
-
1
-
2021/02/24
-
Disclosed
-
Five Ways that COVID-19 Diagnostics Can Save Lives : Prioritizing Uses of Tests to Maximize Cost-Effectiveness
-
positive return on investment